Angiogenesis
During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
- B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent
- B1115 BAY 87-2243Target: Hypoxia Inducible Factors (HIFs)Summary: HIF-1 inhibitor,potent and selective
- B3708 RGD (Arg-Gly-Asp) Peptides1 CitationTarget: Integrin-ligand interactionsSummary: Inhibits integrin binding to RGD motifs
- B7412 RGDS peptideSummary: Integrin binding sequence that inhibits integrin receptor function
- B5391 Echistatin, α1 isoformSummary: Potent irreversible αVβ3 integrin antagonist
- B5644 LDV FITCSummary: fluorescent ligand that binds to the α4β1 integrin (VLA-4)
- B5675 ObtustatinSummary: integrin α1β1 inhibitor
- B5699 P11Summary: antagonist of the integrin αvβ3-vitronectin interaction
- B6664 GR 144053 trihydrochlorideSummary: platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist
- B6764 Combretastatin A4Summary: tubulin polymerization inhibitor